HESKA CORP of LOVELAND, CO filed a DEFA14A with the SEC on 2023-04-03. Industry: In Vitro & In Vivo Diagnostic Substances.
| Seq | Type | Description |
|---|---|---|
| 1 | DEFA14A | DEFA14A |
| 2 | EX-2.1 | EXHIBIT 2.1 |
| 3 | EX-2.2 | EXHIBIT 2.2 |
| 4 | EX-99.1 | EXHIBIT 99.1 |
| 5 | EX-99.2 | EXHIBIT 99.2 |
| 6 | GRAPHIC | image00001.jpg |
| 7 | GRAPHIC | image00002.jpg |
| 8 | GRAPHIC | image00003.jpg |
Showing 12 of 60 filings.
| Filed | Form |
|---|---|
| 2023-06-01 | DEFA14A |
| 2023-05-26 | DEFA14A |
| 2023-05-08 | DEFM14A |
| 2023-04-28 | PREM14A |
| 2023-04-03 | DEFA14A |
| 2023-04-03 | DEFA14A |
| 2023-03-21 | DEFA14A |
| 2023-03-21 | DEF 14A |
| 2022-04-26 | DEFA14A |
| 2022-03-21 | DEFA14A |
| 2022-03-21 | DEF 14A |
| 2021-10-13 | DEFA14A |